We are monitoring the impact of COVID-19 on Latin America Acne Medication Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6566
Share on
Share on

Latin America Acne Medication Market Research Report – Segmented By Type, Route Of Administration, Drug Class and Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6566
Pages: 145

The size of the Latin America Acne Medication Market is projected to showcase a steady growth rate from 2021 to 2026.

Acne is a skin disease which is characterized by pimples, oily skin and blackheads. It can be caused due to dead skin cells, clogged hair follicles and oil from the skin. It generally affects the region with a considerably higher number of sweat glands like upper part of chest, back and face.

Unhealthy urban lifestyle and growing number of cases of acne are the major factors driving the market growth. As people are becoming conscious about their looks, the market is expected to propel during the forecast period. However, side effects associated with the use of acne medication and alternative treatments available in the market are hampering the market growth.

The market for Acne Medication is broadly categorized into type, route of administration and drug class. By type the market is divided into OTC and prescription drugs. By route of administration the market is segmented into Oral and topical. By drug class the market is classified into Antibiotics, anti-inflammatory drugs, anti-microbial, combination drugs, hormonal agents, oral retinoids and topical retinoids. Anti-inflammatory segment holds a major share of the market revenue. On the basis of geography, the market is analysed under various regions namely Argentina, Brazil, Mexico and rest of Latin America.

Some of the major companies dominating the market, by their products and services include Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Type                                                              

                                5.1.1 Introduction                                           

                                5.1.2 OTC drugs                                

                                5.1.3 Prescription drugs                                

                                5.1.4  Y-o-Y Growth Analysis, By type                                     

                                5.1.5  Market Attractiveness Analysis, By type                                   

                                5.1.6 Market Share Analysis, By type                                      

                5.2 Route of administration                                                        

                                5.2.1 Introduction                                           

                                5.2.2 Topical                                      

                                5.2.3 Oral                                            

                                5.2.4 Y-o-Y Growth Analysis, By route of administration                                

                                5.2.5 Market Attractiveness Analysis, By route of administration                                              

                                5.2.6 Market Share Analysis, By route of administration                                

                5.3 Drug class                                                    

                                5.3.1 Introduction                                           

                                5.3.2 Antibiotics                                               

                                5.3.3 Anti-inflammatory drugs                                   

                                5.3.4 Anti-microbials                                      

                                5.3.5 Combination drugs                                              

                                5.3.6 Hormonal agents                                  

                                5.3.7 Oral retinoids                                         

                                5.3.8 Topical retinoids                                   

                                5.3.7 Y-o-Y Growth Analysis, By drug class                                            

                                5.3.8  Market Attractiveness Analysis, By drug class                                         

                                5.3.9  Market Share Analysis, By drug class                                          

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By type                 

                                                6.1.3.3 By route of administration                            

                                                6.1.3.4 By drug class                       

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By type                 

                                                6.1.4.3 By route of administration                            

                                                6.1.4.4 By drug class                       

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By type                 

                                                6.1.5.3 By route of administration                            

                                                6.1.5.4 By drug class                       

                6.2 Brazil                                                             

                6.3 Mexico                                                         

                6.4 Rest of Latin America                                                             

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Pfizer Inc.                                                    

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 GlaxoSmithKline plc                                                

                8.3 Novartis AG                                                

                8.4 Merck & Co. Inc                                                        

                8.5 Amgen, Inc.                                                

                8.6 Abbott Laboratories                                                               

                8.7 Eli Lilly and Company                                                              

                8.8 Daiichi Sankyo Company, Ltd                                                              

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of route, by Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Latin America Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  2. Latin America Otc drugs Market, By Region, From 2021 to 2026 (USD Billion)
  3. Latin America Prescription drugs Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  5. Latin America Topical Market, By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Oral Market, By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  8. Latin America Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Anti-inflammatory  Market, By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Antimicrobials Market, By Region, From 2021 to 2026 (USD Billion)
  11. Latin America Combination Market, By Region, From 2021 to 2026 (USD Billion)
  12. Latin America Hormonla agents Market, By Region, From 2021 to 2026 (USD Billion)
  13. Latin America Oral retinoids Market, By Region, From 2021 to 2026 (USD Billion)
  14. Latin America Topical retinoids Market, By Region, From 2021 to 2026 (USD Billion)
  15. Brazil Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  16. Brazil Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  17. Brazil Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  18. Argentina Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  19. Argentina Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  20. Argentina Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  21. Mexico Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  22. Mexico Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  23. Mexico Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  24. Rest of Latin America Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  25. Rest of Latin America Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  26. Rest of Latin America Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample